Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.
Press releases published on July 1, 2025
Middle East's largest conference & expo is back in Dubai focusing on Bitumen, Petrochemicals, PetroProducts & Logistics
EIN Presswire
·
July 1, 2025
DUBAI, DUBAI, UNITED ARAB EMIRATES, July 1, 2025 /EINPresswire.com/ -- Rex Conferences is pleased to announce the upcoming edition of its premier industry gathering – the Rex Fuels Global Expo …
CubeSmart Announces the Date of Its Second Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
July 1, 2025
MALVERN, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced that the Company will release financial results for the three-month period ended June 30, 2025 after the market close on Thursday, July 31, 2025. An accompanying …
Orion Energy Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
MANITOWOC, Wis., July 01, 2025 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle charging station and maintenance service solutions, announced today that the …
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
GlobeNewswire
·
July 1, 2025
HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, 2025, as the date of its 2025 annual …
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 1, 2025
PASADENA, CALIF, July 01, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered into a definitive agreement with …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
FutureFuel to Release Second Quarter 2025 Financial Results on August 11, 2025
GlobeNewswire
·
July 1, 2025
CLAYTON, Mo., July 01, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release its second quarter 2025 financial results after market close …
Constellation Brands Reports First Quarter Fiscal 2026 Financial Results
GlobeNewswire
·
July 1, 2025
ROCHESTER, N.Y., July 01, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its first quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook …
Clearwater Properties Celebrates Grand Re-Opening of White Sulphur Springs Office
GlobeNewswire
·
July 1, 2025
WHITE SULPHUR SPRINGS, Mont., July 01, 2025 (GLOBE NEWSWIRE) -- Clearwater Properties proudly celebrated the grand re-opening of its White Sulphur Springs office on Friday, June 27, 2025. The event, held from 4:00 p.m. to 8:00 p.m., welcomed community …
Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release an Conference Call
GlobeNewswire
·
July 1, 2025
CHATTANOOGA, Tenn., July 01, 2025 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) announced its plans to release its second quarter earnings after 4:00 p.m. Eastern time on Wednesday, July 23, 2025. Covenant Logistics Group, Inc. will hold …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
Eos Energy Announces Second Funding Under Its Department of Energy Loan Guarantee to Fuel U.S. Battery Manufacturing Capacity Expansion
GlobeNewswire
·
July 1, 2025
TURTLE CREEK, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy …
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and …
ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
July 1, 2025
NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it …
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
GlobeNewswire
·
July 1, 2025
ORR of 50% in treatment-naïve patients with HPV+ R/M HNSCC 12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CHARLESTOWN, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 105,330 restricted …
Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer
GlobeNewswire
·
July 1, 2025
MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including …
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of June 26, 2025, the Board of Directors granted Jean- …
Programmatic Ad Seller Misrepresentation on Connected TV Q1 2025: Pixalate Estimates 13% of Global Open Programmatic CTV Ad Impressions Sold by Unauthorized Sellers
GlobeNewswire
·
July 1, 2025
London, July 01, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2025 Programmatic Ad Seller Misrepresentation Report for Connected TV (CTV). The report uses …
Programmatic Ad Seller Misrepresentation in Mobile Apps Q1 2025: Pixalate Estimates 35% of Global Open Programmatic Mobile App Ad Impressions Sold by Unauthorized Sellers
GlobeNewswire
·
July 1, 2025
London, July 01, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2025 Programmatic Ad Seller Misrepresentation Report for Mobile Apps. The report uses SCO data to examine …